· Periodic Report
Q3 operating loss of KRW 6.9 billion; cumulative operating loss of KRW 21.8 billion
Algenomics sold KRW 0.4 billion in Q3 and lost KRW 6.9 billion from its main business, with a KRW 21.8 billion loss from January to September.
476830 · KOSDAQ · Based on DART filings
3 total · 20 per page
· Periodic Report
Algenomics sold KRW 0.4 billion in Q3 and lost KRW 6.9 billion from its main business, with a KRW 21.8 billion loss from January to September.
· Report on Large ShareholdingsMajor
Korea Development Bank cut its stake in Algenomics from 6.21% to 4.99% through on-market sales of part of its holdings.
· Report on Large Shareholdings
The stake of the CEO and largest shareholder and 11 related parties in Rznomics Inc. moved from 23.90% to 23.87% as voting shares in issue increased.
Get app alerts for new disclosures from Rznomics Inc..